Hongwei Du
- Oncology top 5%
- Immunology top 5%
- Biomedical Engineering top 10%
- Molecular Biology
- Genetics top 10%
- Co-authors
- Gianpietro DottiBarbara SavoldoPeishun ShouYu‐Hui ChenChuang SunYang XuXiaochen WangDavid H. Olson
- Topics
- CAR-T cell therapy research (17 papers)Nanowire Synthesis and Applications (7 papers)Immunotherapy and Immune Responses (4 papers)
- Cited by
- AgingOncologyImmunology
- Journals
- ScienceNature CommunicationsBlood
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Hongwei Du
46 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 109
- Oncology 825
- Immunology 465
- Biomedical Engineering 459
- Molecular Biology 438
- Genetics 200
Countries citing papers authored by Hongwei Du
This map shows the geographic impact of Hongwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Du more than expected).
Fields of papers citing papers by Hongwei Du
This network shows the impact of papers produced by Hongwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Du. The network helps show where Hongwei Du may publish in the future.
Co-authorship network of co-authors of Hongwei Du
This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Du. A scholar is included among the top collaborators of Hongwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Du. Hongwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 8 | |
| 10 | 57 | |
| 11 | 8 | |
| 12 | 197 | |
| 13 | 100 | |
| 14 | 139 | |
| 15 | 3 | |
| 16 | 37 | |
| 17 | 137 | |
| 18 | 14 | |
| 19 | 18 | |
| 20 | 26 |
About Hongwei Du
Hongwei Du is a scholar working on Aging, Bioengineering and Oncology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (17 papers), Nanowire Synthesis and Applications (7 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Aging (57 citations), Oncology (825 citations) and Immunology (465 citations). Hongwei Du has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Gianpietro Dotti, Barbara Savoldo, Peishun Shou, Yu‐Hui Chen, Chuang Sun, Yang Xu, Xiaochen Wang, David H. Olson, Koichi Hirabayashi and Bin Liu. Their work appears in journals such as Science, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.